{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:18:48Z","timestamp":1794565128233,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001106","name":"New South Wales Workers\u2019 Compensation Dust Disease Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001106","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Malignant pleural effusions (MPEs) are common. MPE causes significant breathlessness and impairs quality of life. Indwelling pleural catheters (IPC) allow ambulatory drainage and reduce hospital days and re-intervention rates when compared to standard talc slurry pleurodesis. Daily drainage accelerates pleurodesis, and talc instillation via the IPC has been proven feasible and safe. Surgical pleurodesis via video-assisted thoracoscopic surgery (VATS) is considered a one-off intervention for MPE and is often recommended to patients who are fit for surgery. The AMPLE-3 trial is the first randomised trial to compare IPC (\u00b1talc pleurodesis) and VATS pleurodesis in those who are fit for surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods and analysis<\/jats:title>\n                <jats:p>A multi-centre, open-labelled randomised trial of patients with symptomatic MPE, expected survival of \u2265 6\u2009months and good performance status randomised 1:1 to either IPC or VATS pleurodesis. Participant randomisation will be minimised for (i) cancer type (mesothelioma vs non-mesothelioma); (ii) previous pleurodesis (vs not); and (iii) trapped lung, if known (<jats:italic>vs<\/jats:italic> not). Primary outcome is the need for further ipsilateral pleural interventions over 12\u2009months or until death, if sooner. Secondary outcomes include days in hospital, quality of life (QoL) measures, physical activity levels, safety profile, health economics, adverse events, and survival. The trial will recruit 158 participants who will be followed up for 12\u2009months.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Ethics and dissemination<\/jats:title>\n                <jats:p>Sir Charles Gairdner and Osborne Park Health Care Group (HREC) has approved the study (reference: RGS356). Results will be published in peer-reviewed journals and presented at scientific meetings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>Both IPC and VATS are commonly used procedures for MPE. The AMPLE-3 trial will provide data to help define the merits and shortcomings of these procedures and inform future clinical care algorithms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Australia New Zealand Clinical Trial Registry <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=373133\">ACTRN12618001013257<\/jats:ext-link>. Registered on 18 June 2018.<\/jats:p>\n                <jats:p>Protocol version: Version 3.00\/4.02.19<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-022-06405-7","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T06:03:13Z","timestamp":1656309793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (\u00b1talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8668-1788","authenticated-orcid":false,"given":"Deirdre B.","family":"Fitzgerald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charley","family":"Budgeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai Ling","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Read","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin C. H.","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola Ann","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward T.","family":"Fysh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeevan","family":"Muruganandan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tajalli","family":"Saghaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjan","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Badiei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phan","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Goddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Windsor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasia","family":"Czarnecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parthipan","family":"Sivakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Yasufuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Feller-Kopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick A.","family":"Maskell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. C. Gary","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,27]]},"reference":[{"issue":"5","key":"6405_CR1","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1378\/chest.104.5.1486","volume":"104","author":"M Marel","year":"1993","unstructured":"Marel M, Zrustova M, Stasny B, Light RW. The incidence of pleural effusion in a well-defined region. Epidemiologic study in central Bohemia. Chest. 1993;104(5):1486\u20139.","journal-title":"Chest"},{"issue":"6","key":"6405_CR2","first-page":"E254","volume":"5","author":"N van Zandwijk","year":"2013","unstructured":"van Zandwijk N, Clarke C, Henderson D, et al. Guidelines for the diagnosis and treatment of malignant pleural mesothelioma. J Thorac Dis. 2013;5(6):E254\u2013307.","journal-title":"J Thorac Dis"},{"issue":"4","key":"6405_CR3","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.chest.2016.11.010","volume":"151","author":"N Taghizadeh","year":"2017","unstructured":"Taghizadeh N, Fortin M, Tremblay A. US hospitalizations for malignant pleural effusions: data from the 2012 national inpatient sample. Chest. 2017;151(4):845\u201354.","journal-title":"Chest"},{"issue":"12","key":"6405_CR4","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1136\/thoraxjnl-2014-205285","volume":"69","author":"AO Clive","year":"2014","unstructured":"Clive AO, Kahan BC, Hooper CE, et al. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax. 2014;69(12):1098\u2013104.","journal-title":"Thorax"},{"issue":"1","key":"6405_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1378\/chest.117.1.79","volume":"117","author":"JE Heffner","year":"2000","unstructured":"Heffner JE, Nietert PJ, Barbieri C. Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions. Chest. 2000;117(1):79\u201386.","journal-title":"Chest"},{"issue":"2","key":"6405_CR6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1378\/chest.11-2657","volume":"142","author":"ET Fysh","year":"2012","unstructured":"Fysh ET, Waterer GW, Kendall PA, et al. Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion. Chest. 2012;142(2):394\u2013400.","journal-title":"Chest"},{"issue":"3","key":"6405_CR7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/0003-4975(92)90428-7","volume":"54","author":"MJ Mack","year":"1992","unstructured":"Mack MJ, Aronoff RJ, Acuff TE, Douthit MB, Bowman RT, Ryan WH. Present role of thoracoscopy in the diagnosis and treatment of diseases of the chest. Ann Thorac Surg. 1992;54(3):403\u20138.","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"6405_CR8","first-page":"414","volume":"24","author":"M Scarci","year":"2017","unstructured":"Scarci M, Caruana E, Bertolaccini L, et al. Current practices in the management of malignant pleural effusions: a survey among members of the European Society of Thoracic Surgeons. Interact Cardiovasc Thorac Surg. 2017;24(3):414\u20137.","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"4","key":"6405_CR9","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.athoracsur.2012.01.103","volume":"94","author":"BM Hunt","year":"2012","unstructured":"Hunt BM, Farivar AS, Vallieres E, et al. Thoracoscopic talc versus tunneled pleural catheters for palliation of malignant pleural effusions. Ann Thorac Surg. 2012;94(4):1053\u20137.","journal-title":"Ann Thorac Surg"},{"key":"6405_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1749-8090-5-27","volume":"5","author":"N Barbetakis","year":"2010","unstructured":"Barbetakis N, Asteriou C, Papadopoulou F, et al. Early and late morbidity and mortality and life expectancy following thoracoscopic talc insufflation for control of malignant pleural effusions: a review of 400 cases. J Cardiothorac Surg. 2010;5:27.","journal-title":"J Cardiothorac Surg"},{"issue":"6","key":"6405_CR11","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/S0003-4975(01)02586-3","volume":"71","author":"M Schulze","year":"2001","unstructured":"Schulze M, Boehle AS, Kurdow R, Dohrmann P, Henne-Bruns D. Effective treatment of malignant pleural effusion by minimal invasive thoracic surgery: thoracoscopic talc pleurodesis and pleuroperitoneal shunts in 101 patients. Ann Thorac Surg. 2001;71(6):1809\u201312.","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"6405_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.hlc.2005.02.004","volume":"14","author":"D Trotter","year":"2005","unstructured":"Trotter D, Aly A, Siu L, Knight S. Video-assisted thoracoscopic (VATS) pleurodesis for malignant effusion: an Australian teaching hospital\u2019s experience. Heart Lung Circ. 2005;14(2):93\u20137.","journal-title":"Heart Lung Circ"},{"issue":"6","key":"6405_CR13","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1136\/thoraxjnl-2012-203043","volume":"68","author":"ET Fysh","year":"2013","unstructured":"Fysh ET, Tan SK, Read CA, et al. Pleurodesis outcome in malignant pleural mesothelioma. Thorax. 2013;68(6):594\u20136.","journal-title":"Thorax"},{"issue":"6","key":"6405_CR14","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00464-005-0534-6","volume":"20","author":"K Arapis","year":"2006","unstructured":"Arapis K, Caliandro R, Stern JB, Girard P, Debrosse D, Gossot D. Thoracoscopic palliative treatment of malignant pleural effusions: results in 273 patients. Surg Endosc. 2006;20(6):919\u201323.","journal-title":"Surg Endosc"},{"issue":"2","key":"6405_CR15","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S1010-7940(01)01130-7","volume":"21","author":"G Cardillo","year":"2002","unstructured":"Cardillo G, Facciolo F, Carbone L, et al. Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions. Eur J Cardiothorac Surg. 2002;21(2):302\u20135.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"3","key":"6405_CR16","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1378\/chest.127.3.909","volume":"127","author":"CM Dresler","year":"2005","unstructured":"Dresler CM, Olak J, Herndon JE 2nd, et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest. 2005;127(3):909\u201315.","journal-title":"Chest"},{"issue":"7","key":"6405_CR17","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1308\/003588408X318246","volume":"90","author":"AR Medford","year":"2008","unstructured":"Medford AR, Awan YM, Marchbank A, Rahamim J, Unsworth-White J, Pearson PJ. Diagnostic and therapeutic performance of video-assisted thoracoscopic surgery (VATS) in investigation and management of pleural exudates. Ann R Coll Surg Engl. 2008;90(7):597\u2013600.","journal-title":"Ann R Coll Surg Engl"},{"issue":"4","key":"6405_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/1759-7714.12354","volume":"7","author":"DW Yoon","year":"2016","unstructured":"Yoon DW, Cho JH, Choi YS, et al. Predictors of survival in patients who underwent video-assisted thoracic surgery talc pleurodesis for malignant pleural effusion. Thorac Cancer. 2016;7(4):393\u20138.","journal-title":"Thorac Cancer"},{"issue":"3","key":"6405_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1510\/icvts.2005.118018","volume":"5","author":"T Laisaar","year":"2006","unstructured":"Laisaar T, Palmiste V, Vooder T, Umbleja T. Life expectancy of patients with malignant pleural effusion treated with video-assisted thoracoscopic talc pleurodesis. Interact Cardiovasc Thorac Surg. 2006;5(3):307\u201310.","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"1","key":"6405_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jpainsymman.2005.01.015","volume":"30","author":"A Marrazzo","year":"2005","unstructured":"Marrazzo A, Noto A, Casa L, et al. Video-thoracoscopic surgical pleurodesis in the management of malignant pleural effusion: the importance of an early intervention. J Pain Symptom Manage. 2005;30(1):75\u20139.","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"6405_CR21","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/ALN.0000000000001576","volume":"126","author":"EO Bayman","year":"2017","unstructured":"Bayman EO, Parekh KR, Keech J, Selte A, Brennan TJ. A prospective study of chronic pain after thoracic surgery. Anesthesiology. 2017;126(5):938\u201351.","journal-title":"Anesthesiology"},{"issue":"19","key":"6405_CR22","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1001\/jama.2017.17426","volume":"318","author":"R Thomas","year":"2017","unstructured":"Thomas R, Fysh ETH, Smith NA, et al. Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion: the AMPLE Randomized Clinical Trial. JAMA. 2017;318(19):1903\u201312.","journal-title":"JAMA"},{"issue":"22","key":"6405_CR23","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1001\/jama.2012.5535","volume":"307","author":"HE Davies","year":"2012","unstructured":"Davies HE, Mishra EK, Kahan BC, et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA. 2012;307(22):2383\u20139.","journal-title":"JAMA"},{"issue":"10","key":"6405_CR24","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<1992::AID-CNCR16>3.0.CO;2-M","volume":"86","author":"JB Putnam Jr","year":"1999","unstructured":"Putnam JB Jr, Light RW, Rodriguez RM, et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer. 1999;86(10):1992\u20139.","journal-title":"Cancer"},{"issue":"6","key":"6405_CR25","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1510\/icvts.2009.211516","volume":"9","author":"CA Efthymiou","year":"2009","unstructured":"Efthymiou CA, Masudi T, Thorpe JA, Papagiannopoulos K. Malignant pleural effusion in the presence of trapped lung. Five-year experience of PleurX tunnelled catheters. Interact Cardiovasc Thorac Surg. 2009;9(6):961\u20134.","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"2","key":"6405_CR26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1177\/021849230801600208","volume":"16","author":"RA Qureshi","year":"2008","unstructured":"Qureshi RA, Collinson SL, Powell RJ, Froeschle PO, Berrisford RG. Management of malignant pleural effusion associated with trapped lung syndrome. Asian Cardiovasc Thorac Ann. 2008;16(2):120\u20133.","journal-title":"Asian Cardiovasc Thorac Ann"},{"issue":"2","key":"6405_CR27","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1378\/chest.129.2.362","volume":"129","author":"A Tremblay","year":"2006","unstructured":"Tremblay A, Michaud G. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest. 2006;129(2):362\u20138.","journal-title":"Chest"},{"issue":"8","key":"6405_CR28","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1164\/rccm.201607-1404OC","volume":"195","author":"MM Wahidi","year":"2017","unstructured":"Wahidi MM, Reddy C, Yarmus L, et al. Randomized trial of pleural fluid drainage frequency in patients with malignant pleural effusions. The ASAP Trial. Am J Respir Crit Care Med. 2017;195(8):1050\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"6405_CR29","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S2213-2600(18)30288-1","volume":"6","author":"S Muruganandan","year":"2018","unstructured":"Muruganandan S, Azzopardi M, Fitzgerald DB, et al. Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial. Lancet Respir Med. 2018;6(9):671\u201380.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"6405_CR30","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1378\/chest.10-1868","volume":"139","author":"C Reddy","year":"2011","unstructured":"Reddy C, Ernst A, Lamb C, Feller-Kopman D. Rapid pleurodesis for malignant pleural effusions: a pilot study. Chest. 2011;139(6):1419\u201323.","journal-title":"Chest"},{"issue":"6","key":"6405_CR31","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1378\/chest.14-0394","volume":"146","author":"L Ahmed","year":"2014","unstructured":"Ahmed L, Ip H, Rao D, Patel N, Noorzad F. Talc pleurodesis through indwelling pleural catheters for malignant pleural effusions: retrospective case series of a novel clinical pathway. Chest. 2014;146(6):e190\u20134.","journal-title":"Chest"},{"issue":"14","key":"6405_CR32","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1056\/NEJMoa1716883","volume":"378","author":"R Bhatnagar","year":"2018","unstructured":"Bhatnagar R, Keenan EK, Morley AJ, et al. Outpatient talc administration by indwelling pleural catheter for malignant effusion. N Engl J Med. 2018;378(14):1313\u201322.","journal-title":"N Engl J Med"},{"issue":"5","key":"6405_CR33","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1378\/chest.12-3103","volume":"144","author":"ET Fysh","year":"2013","unstructured":"Fysh ET, Tremblay A, Feller-Kopman D, et al. Clinical outcomes of indwelling pleural catheter-related pleural infections: an international multicenter study. Chest. 2013;144(5):1597\u2013602.","journal-title":"Chest"},{"issue":"1","key":"6405_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11606-010-1472-0","volume":"26","author":"ME Van Meter","year":"2011","unstructured":"Van Meter ME, McKee KY, Kohlwes RJ. Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review. J Gen Intern Med. 2011;26(1):70\u20136.","journal-title":"J Gen Intern Med"},{"issue":"3","key":"6405_CR35","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1378\/chest.14-2401","volume":"148","author":"R Thomas","year":"2015","unstructured":"Thomas R, Piccolo F, Miller D, et al. Intrapleural fibrinolysis for the treatment of indwelling pleural catheter-related symptomatic loculations: a multicenter observational study. Chest. 2015;148(3):746\u201351.","journal-title":"Chest"},{"issue":"3","key":"6405_CR36","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1378\/chest.13-3057","volume":"146","author":"R Thomas","year":"2014","unstructured":"Thomas R, Budgeon CA, Kuok YJ, et al. Catheter tract metastasis associated with indwelling pleural catheters. Chest. 2014;146(3):557\u201362.","journal-title":"Chest"},{"issue":"1","key":"6405_CR37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1089\/jpm.2009.0220","volume":"13","author":"AM Olden","year":"2010","unstructured":"Olden AM, Holloway R. Treatment of malignant pleural effusion: PleuRx catheter or talc pleurodesis? A cost-effectiveness analysis. J Palliat Med. 2010;13(1):59\u201365.","journal-title":"J Palliat Med"},{"issue":"2","key":"6405_CR38","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.athoracsur.2012.02.100","volume":"94","author":"V Puri","year":"2012","unstructured":"Puri V, Pyrdeck TL, Crabtree TD, et al. Treatment of malignant pleural effusion: a cost-effectiveness analysis. Ann Thorac Surg. 2012;94(2):374\u20139 discussion 379-380.","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"6405_CR39","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1378\/chest.13-2481","volume":"146","author":"ED Penz","year":"2014","unstructured":"Penz ED, Mishra EK, Davies HE, Manns BJ, Miller RF, Rahman NM. Comparing cost of indwelling pleural catheter vs talc pleurodesis for malignant pleural effusion. Chest. 2014;146(4):991\u20131000.","journal-title":"Chest"},{"issue":"7","key":"6405_CR40","doi-asserted-by":"publisher","first-page":"e011480","DOI":"10.1136\/bmjopen-2016-011480","volume":"6","author":"M Azzopardi","year":"2016","unstructured":"Azzopardi M, Thomas R, Muruganandan S, et al. Protocol of the Australasian Malignant Pleural Effusion-2 (AMPLE-2) trial: a multicentre randomised study of aggressive versus symptom-guided drainage via indwelling pleural catheters. BMJ Open. 2016;6(7):e011480.","journal-title":"BMJ Open"},{"key":"6405_CR41","doi-asserted-by":"crossref","unstructured":"Jeffery E, Lee YG, McVeigh J, et al. Feasibility of objectively measured physical activity and sedentary behavior in patients with malignant pleural effusion. Support Care Cancer. 2017. [Epub ahead of print].","DOI":"10.1007\/s00520-017-3721-9"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06405-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06405-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06405-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T06:04:21Z","timestamp":1656309861000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06405-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,27]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6405"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06405-7","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,27]]},"assertion":[{"value":"6 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial has been approved by the Sir Charles Gairdner and Osborne Park Health Care Group (HREC) for WA Health hospitals, Northern and St Vincent\u2019s (Melbourne) Hospitals, Victoria; Royal Adelaide Hospital, South Australia; St George, Westmead, John Hunter, the Sutherland and Concord Repatriation General Hospitals, New South Wales; Sunshine Coast University and The Prince Charles Hospitals, Queensland; University Health Network Research Ethics Board for Toronto General Hospital, Canada; St John of God Health Care Human Research Ethics Committee for Midland and Murdoch Hospitals, Western Australia; Health and Disability Ethics Committees for Wellington Hospital, New Zealand; Hollywood Private Hospital Research Ethics Committee for Hollywood Private Hospital, WA. All participants will sign a consent form prior to enrolment in the study, including consent for publication of the anonymised data. A model consent form is available on request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Rocket Medical (UK) Plc has provided free drainage kits and an unrestricted educational grant for previous clinical trials led by YCGL but was not involved in the conception, design, or management of the study, the protocol, the statistical analysis, or the plan for dissemination. NAM reports grants from BD Carefusion, personal fees from BD Carefusion, and personal fees from Cook Medical, outside the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"530"}}